．

Material Information - Update on the Company's IND Application of Phase I Clinical Trial of TCRT-ESO-A2-TW in Patients with Advanced Solid Tumors

Apr 30, 2025

20250430 T細胞受體免疫療法TCRT-ESO-A2-TW用於治療末期實體腫瘤患者之第一期臨床試驗申請案（IND）進度更新 (EN).pdf

Download